Literature DB >> 25459681

Modulation of the mitochondrial voltage dependent anion channel (VDAC) by curcumin.

Debanjan Tewari1, Tofayel Ahmed1, Venkat R Chirasani1, Pradeep K Singh2, Samir K Maji2, Sanjib Senapati1, Amal Kanti Bera3.   

Abstract

Voltage dependent anion channel (VDAC) of mitochondria plays a crucial role in apoptosis. Human VDAC-1, reconstituted in planar lipid bilayer showed reduced conductance when treated with curcumin. Curcumin interacts with residues in the α helical N-terminus of VDAC and in the channel wall, as revealed by molecular docking, followed by mutational analysis. N-terminus mimicking peptide showed conformational changes in circular dichroism, upon curcumin treatment. We propose that the interaction of curcumin with amino acids in N-terminus and in channel wall fixes the α helix in closed conformation. This restricts its movement which is required for the opening of the channel.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Curcumin; Gating; Ion channel; Mitochondria; VDAC

Mesh:

Substances:

Year:  2014        PMID: 25459681     DOI: 10.1016/j.bbamem.2014.10.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

Review 1.  Mitochondria-Centric Review of Polyphenol Bioactivity in Cancer Models.

Authors:  Jan F Stevens; Johana S Revel; Claudia S Maier
Journal:  Antioxid Redox Signal       Date:  2017-12-11       Impact factor: 8.401

2.  Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells.

Authors:  Sarah A Head; Wei Shi; Liang Zhao; Kirill Gorshkov; Kalyan Pasunooti; Yue Chen; Zhiyou Deng; Ruo-jing Li; Joong Sup Shim; Wenzhi Tan; Thomas Hartung; Jin Zhang; Yingming Zhao; Marco Colombini; Jun O Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-10       Impact factor: 11.205

Review 3.  Pharmacological modulation of mitochondrial ion channels.

Authors:  Luigi Leanza; Vanessa Checchetto; Lucia Biasutto; Andrea Rossa; Roberto Costa; Magdalena Bachmann; Mario Zoratti; Ildiko Szabo
Journal:  Br J Pharmacol       Date:  2019-01-02       Impact factor: 8.739

Review 4.  Disease-modifying treatment of Parkinson's disease by phytochemicals: targeting multiple pathogenic factors.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2021-10-15       Impact factor: 3.850

Review 5.  Mitochondrial ion channels in pancreatic β-cells: Novel pharmacological targets for the treatment of Type 2 diabetes.

Authors:  Umberto De Marchi; Silvia Fernandez-Martinez; Sergio de la Fuente; Andreas Wiederkehr; Jaime Santo-Domingo
Journal:  Br J Pharmacol       Date:  2020-03-21       Impact factor: 8.739

6.  After all, plasmalemmal expression of type-1 VDAC can be understood. Phosphorylation, nitrosylation, and channel modulators work together in vertebrate cell volume regulation and either apoptotic pathway.

Authors:  Friedrich P Thinnes
Journal:  Front Physiol       Date:  2015-04-27       Impact factor: 4.566

7.  Plasmalemmal VDAC-1 corroborated as amyloid Aß-receptor.

Authors:  Friedrich P Thinnes
Journal:  Front Aging Neurosci       Date:  2015-09-30       Impact factor: 5.750

8.  N-helix and Cysteines Inter-regulate Human Mitochondrial VDAC-2 Function and Biochemistry.

Authors:  Svetlana Rajkumar Maurya; Radhakrishnan Mahalakshmi
Journal:  J Biol Chem       Date:  2015-10-20       Impact factor: 5.157

Review 9.  VDAC1 as Pharmacological Target in Cancer and Neurodegeneration: Focus on Its Role in Apoptosis.

Authors:  Andrea Magrì; Simona Reina; Vito De Pinto
Journal:  Front Chem       Date:  2018-04-06       Impact factor: 5.221

10.  Intrinsic OXPHOS limitations underlie cellular bioenergetics in leukemia.

Authors:  Margaret Am Nelson; Kelsey L McLaughlin; James T Hagen; Hannah S Coalson; Cameron Schmidt; Miki Kassai; Kimberly A Kew; Joseph M McClung; P Darrell Neufer; Patricia Brophy; Nasreen A Vohra; Darla Liles; Myles C Cabot; Kelsey H Fisher-Wellman
Journal:  Elife       Date:  2021-06-16       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.